← Leaderboards
Caryn Heldt
Michigan Technological University
$1,883,476
Attributed
$2,847,785
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $728K · FY2020–25$1M$750K$500K$250K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
FDA$1,499,999 · 1
NIH$1,347,786 · 4
By mechanism
R01$1,499,999 · 1
R21$843,033 · 2
S10$344,118 · 1
T32$160,635 · 1
Top collaborators
- Michael J Betenbaugh4 shared
- Sarah Louise Perry2 shared
Most similar at Michigan Technological University
Same institution · by research overlap
- Gregory M. Odegard$206,654
- Ashutosh Tiwari$539,333
- Stephen A Hackney$476,329
- Yevgeniy S Nimon$178,439
Others in their field
Other Emerging Leaders on “Virus”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$206,525,404
- Leonard Freedman · Leidos Biomedical Research, Inc.$79,828,969
- Ted Ross · University Of Georgia$71,962,304
- Beth Baseler · Leidos Biomedical Research, Inc.$67,833,289
- Tony Moody · Duke University$66,767,417
- Matthew Johnson · Duke University$61,899,930
Research focus
VirusChemistryHydrophobicityMolecularPropertyEncapsulatedViralAmino AcidsAtomic Force MicroscopyParticleFutureSurfaceChargeStructureSamplingSugarProteinsRuralCellsNanoindentationAffectBaseManufactureMeasurement
Grant awards (10)
Bio Atomic Force Microscope$344,118
S10 · FY2025 · OD · contact PI
Transdisciplinary Predoctoral Training in Health-Integrated Technologies$160,635
T32 · FY2025 · GM · contact PI
Integrated and Continuous Manufacturing of an Influenza Vaccine$235,000
R01 · FY2024 · FD · contact PI
Structural and chemical changes between empty and full AAV capsids$186,408
R21 · FY2024 · AI · contact PI
Integrated and Continuous Manufacturing of an Influenza Vaccine$500,000
R01 · FY2023 · FD · contact PI
Structural and chemical changes between empty and full AAV capsids$228,005
R21 · FY2023 · AI · contact PI
Integrated and Continuous Manufacturing of an Influenza Vaccine$264,999
R01 · FY2022 · FD · contact PI
Integrated and Continuous Manufacturing of an Influenza Vaccine$500,000
R01 · FY2021 · FD · contact PI
Dense Phase Polyelectrolytes to Thermally Stabilize Viral Vaccines$227,457
R21 · FY2021 · AI · contact PI
Dense Phase Polyelectrolytes to Thermally Stabilize Viral Vaccines$201,163
R21 · FY2020 · AI · contact PI